Case Study: a leading global pharmaceutical company achieves 95%+ data acceptability with Clario Respiratory Solutions

Leading Global Pharmaceutical Company boosts data acceptability by 4% with Clario

A leading global pharmaceutical company faced significant data quality challenges in a clinical trial for a new asthma compound. Their study revealed major discrepancies in spirometry results from investigative sites, with 37% of sites receiving low grades for data quality. They partnered with Clario to address these issues with spirometry data collection and acceptability.

Clario implemented its Respiratory Solutions integrated with Enhanced Business Intelligence for Respiratory Trials. This provided weekly custom reports that identified data variability and low-performing sites, enabling targeted interventions like recruitment holds and retraining. As a result, Clario helped the company increase acceptable data by 4%, achieving a rate above 95% overall. This ensured an on-schedule database lock and generated higher-quality data for a successful regulatory submission.